Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Pneumococcal conjugate vaccines and otitis media.

Taylor S, Marchisio P, Vergison A, Hausdorff WP, Haggard M.

Int J Otolaryngol. 2012;2012:764573. doi: 10.1155/2012/764573. Epub 2012 Nov 13. No abstract available.

2.

New vaccines against otitis media: projected benefits and cost-effectiveness.

O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA.

Pediatrics. 2009 Jun;123(6):1452-63. doi: 10.1542/peds.2008-1482.

PMID:
19482754
3.

Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?

van Kempen MJ, Vermeiren JS, Vaneechoutte M, Claeys G, Veenhoven RH, Rijkers GT, Sanders EA, Dhooge IJ.

Int J Pediatr Otorhinolaryngol. 2006 Feb;70(2):275-85. Epub 2005 Sep 2.

PMID:
16140397
4.

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, Griffin MR.

Pediatrics. 2006 Sep;118(3):865-73.

PMID:
16950975
5.

The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age.

Straetemans M, Palmu A, Auranen K, Zielhuis GA, Kilpi T.

Int J Pediatr Otorhinolaryngol. 2003 Nov;67(11):1235-42.

PMID:
14597376
6.

Impact of pneumococcal and influenza vaccines on otitis media.

Jenson HB, Baltimore RS.

Curr Opin Pediatr. 2004 Feb;16(1):58-60. Review.

PMID:
14758115
7.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH; Finnish Otitis Media Study Group..

N Engl J Med. 2001 Feb 8;344(6):403-9.

8.

Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.

Barnett ED, Pelton SI, Cabral HJ, Eavey RD, Allen C, Cunningham MJ, McNamara ER, Klein JO.

Clin Infect Dis. 1999 Jul;29(1):191-2.

PMID:
10433584
9.

Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.

Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM.

Pharmacoeconomics. 2011 Mar;29(3):199-211. doi: 10.2165/11584930-000000000-00000. Review.

PMID:
21250759
10.

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.

Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR.

Pediatrics. 2007 Apr;119(4):707-15. Erratum in: Pediatrics. 2007 Jun;119(6):1270.

PMID:
17403841
11.

[Conjugate pneumococcal vaccines and influence on the ear, nose and throat area].

Almaç A, Kuru FD.

Kulak Burun Bogaz Ihtis Derg. 2011 Nov-Dec;21(6):345-8. doi: 10.5606/kbbihtisas.2011.054. Turkish.

PMID:
22014302
12.

Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine.

Prosser LA, Ray GT, O'Brien M, Kleinman K, Santoli J, Lieu TA.

Pediatrics. 2004 Feb;113(2):283-90.

PMID:
14754939
13.

Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine.

Benninger MS.

Otolaryngol Head Neck Surg. 2008 Mar;138(3):274-8. doi: 10.1016/j.otohns.2007.11.011. Review.

PMID:
18312870
14.

The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?

Dagan R.

Vaccine. 2008 Jun 16;26 Suppl 2:B16-8. doi: 10.1016/j.vaccine.2008.05.019.

PMID:
18793601
15.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K.

Pediatr Infect Dis J. 2000 Mar;19(3):187-95.

PMID:
10749457
16.

Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.

Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D.

J Infect Dis. 2000 Apr;181(4):1322-9. Epub 2000 Apr 7.

PMID:
10753730
17.

Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.

van Heerbeek N, Straetemans M, Wiertsema SP, Ingels KJ, Rijkers GT, Schilder AG, Sanders EA, Zielhuis GA.

Pediatrics. 2006 Mar;117(3):603-8.

PMID:
16510637
18.

Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.

Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA.

J Infect Dis. 1999 May;179(5):1152-6.

PMID:
10191217
19.

Pneumococcal otitis media and pneumococcal vaccines, a historical perspective.

Austrian R.

Vaccine. 2000 Dec 8;19 Suppl 1:S71-7.

PMID:
11163467
20.

Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination.

Menon VJ, Corscadden KJ, Fuery A, Thornton RB, Kirkham LA, Richmond PC, Wiertsema SP.

Vaccine. 2012 Apr 26;30(20):3136-44. doi: 10.1016/j.vaccine.2012.01.086. Epub 2012 Feb 8.

PMID:
22326775

Supplemental Content

Support Center